Obalon Therapeutics, Inc. (NASDAQ:OBLN) fell 8.7% during mid-day trading on Tuesday . The stock traded as low as $3.58 and last traded at $3.97. 1,203,953 shares changed hands during trading, a decline of 93% from the average session volume of 16,547,965 shares. The stock had previously closed at $4.35.
Separately, Alliance Global Partners upgraded shares of Obalon Therapeutics from a “neutral” rating to a “buy” rating in a report on Thursday, February 18th.
The firm’s fifty day moving average price is $3.72 and its 200 day moving average price is $1.69. The company has a current ratio of 1.79, a quick ratio of 1.79 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $30.85 million, a price-to-earnings ratio of -1.90 and a beta of -0.69.
Obalon Therapeutics Company Profile (NASDAQ:OBLN)
Obalon Therapeutics, Inc focuses on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. Its product includes medical balloon technology for weight loss therapy which consists of a capsule containing a balloon that is swallowed and then remotely inflated.
Receive News & Ratings for Obalon Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Obalon Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.